|
Guirao-Abad JP, Sánchez-Fresneda R, Valentín E, Martínez-Esparza M, Argüelles JC. Analysis of validamycin as a potential antifungal compound against Candida albicans. Int Microbiol. 2013 Dec;16(4):217-25. PubMed PMID: 25102722.
AÑO: 2013; IF: 2.3
|
25102722
|
Guirao-Abad JP, Sánchez-Fresneda R, Alburquerque B, Hernández JA, Argüelles JC. ROS formation is a differential contributory factor to the fungicidal action of Amphotericin B and Micafungin in Candida albicans. Int J Med Microbiol. 2017 Jun;307(4-5):241-248. doi: 10.1016/j.ijmm.2017.03.005. Epub 2017 Apr 4. PubMed PMID: 28412040.
AÑO: 2017; IF: 3.6
|
|
Guirao-Abad JP, Sánchez-Fresneda R, Machado F, Argüelles JC, Martínez-Esparza M. Micafungin Enhances the Human Macrophage Response to Candida albicans through β-Glucan Exposure. Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02161-17. doi: 10.1128/AAC.02161-17. Print 2018 May. PubMed PMID: 29483123; PubMed Central PMCID: PMC5923102.
AÑO: 2018; IF: 4.5
|
|
Guirao-Abad JP, Pujante V, Sanchez-Fresneda R, Yague G, Arguelles JC. Sensitivity of the Candida albicans trehalose-deficient mutants tps1Delta and tps2Delta to amphotericin B and micafungin. J Med Microbiol. 2019 Oct;68(10):1479-1488. doi: 10.1099/jmm.0.001053. Epub 2019 Aug 5. PubMed PMID: 31380734.
AÑO: 2019; IF: 2.0
|
|
Arguelles A, Sanchez-Fresneda R, Guirao-Abad JP, Belda C, Lozano JA, Solano F, Arguelles JC. Novel Bi-Factorial Strategy against Candida albicans Viability Using Carnosic Acid and Propolis: Synergistic Antifungal Action. Microorganisms. 2020 May 16;8(5):749. doi: 10.3390/microorganisms8050749. PubMed PMID: 32429493; PubMed Central PMCID: PMC7284847.
AÑO: 2020; IF: 4.128
|